Basic Research on gene transfer using gene-gun against malignant gliomas
Basic Research on gene transfer using gene-gun against malignant gliomas
批准号:
10470285
负责人:
ASAI Akio
金额:
$7.94万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(1) Ex vivo gene transfer with gene-gunWe evaluated gene-gun-mediated ex vivo gene transfer using subcuateous tumor-bearing rat model. First we transplanted 9L glioma cells into F344 syngeneic rats subcutaneously and surgically removed formed tumors 20 days after transplantation. Lac Z expression vector was transduced by gene-guun at shooting pressure (psi) 100, 200, 400, and 600 (max) or Lca Z expressing adenovirus was incubated with the tumor at MOI 20, 40, and 100 for 24 hours. The tumors were then re-transplanted subcutaneously and gene expression was evaluated 7 days after the re-transplantation. The highest gene-gun-mediated gene transfer rate ranged from 3 to 9 % along with shooting pressure whereas that by adenovirus ranged from 5.5 to 15.9% along with MOI which are statistically different.(2) In vivo gene transfer with gene-gunNext, we estimated gene-gun mediated in vivo gene transfer using the same animal model as (1). We surgically opened the skin over the subcutaneously formed tumors and shot Lac Z expression vector at the same psi as (1) or injected Lac Z expression adenovirus at the same MOIs as (1). After the treatments, the wounds were closed and gene expression was examined 7 days after the treatments. The highest gene-gun-mediated gene transfer rate ranged from 3.6 to 9.5 % along with shooting pressure whereas that by adenovirus ranged from 5.8 to 13.2 % along with MOI which are statistically different.In conclusion, although gene transfer with gene-gun is less effective than adenovirus-mediated gene transfer against gliomas, gene-gun-mediated gene transfer is still a good tool to transduce genes in vivo or ex vivo.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sano T, Asai A, Mishima K, Fujimaki T, Kirino T: "Telomerase activity in 144 brain tumors"Br J Cancer. 77. 1633-1637 (1998)
Sano T、Asai A、Mishima K、Fujimaki T、Kirino T:“144 种脑肿瘤中的端粒酶活性”Br J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H: "Relative level of expression of Bax and Bcl-XィイD2LィエD2 determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax."Oncogene. 18. 5703-5713 (1999)
Shinoura N、Yoshida Y、Asai A、Kirino T、Hamada H:“Bax 和 Bcl-XiiD2LieD2 的相对表达水平决定了 Bax 过度表达诱导的细胞凋亡/坏死的命运。”Oncogene。18。5703-5713( 1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ueki K,Chen W-B,Narita Y,Asai A、Kirino T: "Tight association of loss of merlin expression with loss of heterozygosity at chemosome 22q in spoardic meningiomas"Cancer Res. 59. 5995-5998 (1999)
Ueki K、Chen W-B、Narita Y、Asai A、Kirino T:“散发性脑膜瘤中 merlin 表达缺失与化学体 22q 杂合性缺失的紧密关联”Cancer Res. 59. 5995-5998 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinoura N., Yoshida Y., Nishimura M., Muramatsu Y., Asai A., Kirino T., Hamada H.: "Expression level of Bcl-2 determines anti- or proapoptotic function"Cancer Res. 59. 4119-4128 (1999)
Shinoura N.、Yoshida Y.、Nishimura M.、Muramatsu Y.、Asai A.、Kirino T.、Hamada H.:“Bcl-2 的表达水平决定抗凋亡或促凋亡功能”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y: "Oncogenic Ras trigger cell suicide through the activation of a caspase-independent cell death program in human cance
Chi S、Kitanaka C、Noguchi K、Mochizuki T、Nagashima Y、Shirouzu M、Fujita H、Yoshida M、Chen W、Asai A、Himeno M、Yokoyama S、Kuchino Y:“致癌 Ras 通过激活
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Functional analysis of OX40 signal in glioma cancer stem cells
-
批准号:18K08983
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2018
-
负责人:ASAI Akio
-
依托单位:
Basic research on development of dendritic cell therapy targeting glioma cancer stem cells
-
批准号:15K10346
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2015
-
负责人:ASAI Akio
-
依托单位:
Vaccination therapy against malignant glioma using apoptosis-inducing genes
-
批准号:07407038
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$23.23万
-
财政年份:1995
-
负责人:ASAI Akio
-
依托单位:
海外基金